47 related articles for article (PubMed ID: 31900718)
21. Astragaloside IV synergizes with ferulic acid to suppress hepatic stellate cells activation in vitro.
Dong H; Guo H; Liang Y; Wang X; Niu Y
Free Radic Res; 2017 Feb; 51(2):167-178. PubMed ID: 28147890
[TBL] [Abstract][Full Text] [Related]
22. Synergistic anti-liver fibrosis actions of total astragalus saponins and glycyrrhizic acid via TGF-β1/Smads signaling pathway modulation.
Zhou Y; Tong X; Ren S; Wang X; Chen J; Mu Y; Sun M; Chen G; Zhang H; Liu P
J Ethnopharmacol; 2016 Aug; 190():83-90. PubMed ID: 27282665
[TBL] [Abstract][Full Text] [Related]
23. Ferulic acid attenuates liver fibrosis and hepatic stellate cell activation via inhibition of TGF-β/Smad signaling pathway.
Mu M; Zuo S; Wu RM; Deng KS; Lu S; Zhu JJ; Zou GL; Yang J; Cheng ML; Zhao XK
Drug Des Devel Ther; 2018; 12():4107-4115. PubMed ID: 30584275
[TBL] [Abstract][Full Text] [Related]
24. Astragaloside IV and ferulic acid synergistically promote neurite outgrowth through Nrf2 activation.
Liang Y; Zou Y; Niu C; Niu Y
Mech Ageing Dev; 2019 Jun; 180():70-81. PubMed ID: 30978363
[TBL] [Abstract][Full Text] [Related]
25. Protective effects of astragaloside IV on porcine-serum-induced hepatic fibrosis in rats and in vitro effects on hepatic stellate cells.
Liu H; Wei W; Sun WY; Li X
J Ethnopharmacol; 2009 Apr; 122(3):502-8. PubMed ID: 19429320
[TBL] [Abstract][Full Text] [Related]
26. Astragaloside IV Synergizes with Ferulic Acid to Alleviate Hepatic Fibrosis in Bile Duct-Ligated Cirrhotic Rats.
Zhao XM; Zhang J; Liang YN; Niu YC
Dig Dis Sci; 2020 Oct; 65(10):2925-2936. PubMed ID: 31900718
[TBL] [Abstract][Full Text] [Related]
27. Activation of Nrf2/AREs-mediated antioxidant signalling, and suppression of profibrotic TGF-β1/Smad3 pathway: a promising therapeutic strategy for hepatic fibrosis - A review.
Gong Y; Yang Y
Life Sci; 2020 Sep; 256():117909. PubMed ID: 32512009
[TBL] [Abstract][Full Text] [Related]
28. Nuclear erythroid 2-related factor 2: a novel potential therapeutic target for liver fibrosis.
Yang JJ; Tao H; Huang C; Li J
Food Chem Toxicol; 2013 Sep; 59():421-7. PubMed ID: 23793039
[TBL] [Abstract][Full Text] [Related]
29. Peribiliary myofibroblasts in biliary type liver fibrosis.
Kinnman N; Housset C
Front Biosci; 2002 Feb; 7():d496-503. PubMed ID: 11815289
[TBL] [Abstract][Full Text] [Related]
30. Role of cytoglobin, a novel radical scavenger, in stellate cell activation and hepatic fibrosis.
Thuy LTT; Hai H; Kawada N
Clin Mol Hepatol; 2020 Jul; 26(3):280-293. PubMed ID: 32492766
[TBL] [Abstract][Full Text] [Related]
31. Molecular Mechanism of Astragaloside IV in Improving Endothelial Dysfunction of Cardiovascular Diseases Mediated by Oxidative Stress.
Meng P; Yang R; Jiang F; Guo J; Lu X; Yang T; He Q
Oxid Med Cell Longev; 2021; 2021():1481236. PubMed ID: 34840664
[TBL] [Abstract][Full Text] [Related]
32. Ferulic acid: A review of its pharmacology, pharmacokinetics and derivatives.
Li D; Rui YX; Guo SD; Luan F; Liu R; Zeng N
Life Sci; 2021 Nov; 284():119921. PubMed ID: 34481866
[TBL] [Abstract][Full Text] [Related]
33. Natural Products as Sources of Multitarget Compounds: Advances in the Development of Ferulic Acid as Multitarget Therapeutic.
Kaur R; Sood A; Lang DK; Arora R; Kumar N; Diwan V; Saini B
Curr Top Med Chem; 2022 Mar; 22(5):347-365. PubMed ID: 35040403
[TBL] [Abstract][Full Text] [Related]
34. Ferulic acid and hormesis: Biomedical and environmental implications.
Calabrese EJ; Agathokleous E; Calabrese V
Mech Ageing Dev; 2021 Sep; 198():111544. PubMed ID: 34274398
[TBL] [Abstract][Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
